News Focus
News Focus
Followers 48
Posts 7099
Boards Moderated 0
Alias Born 06/17/2009

Re: Investor2014 post# 379529

Sunday, 10/23/2022 9:34:21 AM

Sunday, October 23, 2022 9:34:21 AM

Post# of 517593
Investor, given that the P2b/3 trial in for early AD, don't you think the % of participants on DPZ will be less than the P2a trial, which was mild/moderate AD?

Hopefully, that will be a subset of the in depth analysis: DPZ users vs. non-DPZ users.

ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News